Nondestructive label-free detection of peritumoral white matter damage using cross-polarization optical coherence tomography

Abstract

IntroductionTo improve the quality of brain tumor resections, it is important to differentiate zones with myelinated fibers destruction from tumor tissue and normal white matter. Optical coherence tomography (OCT) is a promising tool for brain tissue visualization and in the present study, we demonstrate the ability of cross-polarization (CP) OCT to detect damaged white matter and differentiate it from normal and tumor tissues.Materials and methodsThe study was performed on 215 samples of brain tissue obtained from 57 patients with brain tumors. The analysis of the obtained OCT data included three stages: 1) visual analysis of structural OCT images; 2) quantitative assessment based on attenuation coefficients estimation in co- and cross-polarizations; 3) building of color-coded maps with subsequent visual analysis. The defining characteristics of structural CP OCT images and color-coded maps were determined for each studied tissue type, and then two classification tests were passed by 8 blinded respondents after a training.ResultsVisual assessment of structural CP OCT images allows detecting white matter areas with damaged myelinated fibers and differentiate them from normal white matter and tumor tissue. Attenuation coefficients also allow distinguishing all studied brain tissue types, while it was found that damage to myelinated fibers leads to a statistically significant decrease in the values of attenuation coefficients compared to normal white matter. Nevertheless, the use of color-coded optical maps looks more promising as it combines the objectivity of optical coefficient and clarity of the visual assessment, which leads to the increase of the diagnostic accuracy of the method compared to visual analysis of structural OCT images.ConclusionsAlteration of myelinated fibers causes changes in the scattering properties of the white matter, which gets reflected in the nature of the received CP OCT signal. Visual assessment of structural CP OCT images and color-coded maps allows differentiating studied tissue types from each other, while usage of color-coded maps demonstrates higher diagnostic accuracy values in comparison with structural images (F-score = 0.85-0.86 and 0.81, respectively). Thus, the results of the study confirm the potential of using OCT as a neuronavigation tool during resections of brain tumors.

Discriminating Glioblastoma from Normal Brain Tissue In Vivo Using Optical Coherence Tomography and Angiography: A Texture and Microvascular Analysis Approach

“…They also discovered that certain parameters, such as attenuation and forward cross-scattering, are effective in distinguishing between normal and tumorous brain tissues. Although previous reports have shown that OCT microstructural results can differentiate tumorous from normal brain tissue, the diagnostic accuracy can be further enhanced by utilizing the functional capabilities of OCT [53].…”

Advances in Diagnostic Tools and Therapeutic Approaches for Gliomas: A Comprehensive Review

“…However, the application of color-coded optical maps emerged as a more promising approach, as it combined the objectivity of optical coefficients with the clarity of visual assessment. This approach substantially improved diagnostic accuracy compared to the visual analysis of structural OCT images [ 86 ]. Bohringer et al conducted a qualitative analysis of OCT images from glial tumors with varying malignancies, identifying signal homogeneity as a key differential criterion.…”

Artificial Intelligence in Neurosurgery: A State-of-the-Art Review from Past to Future

“…AI has also been implemented in surgical procedures to assist in the planning phase, aiding in decision-making during surgery. Its utilization has shown promising results, enhancing the accuracy of surgical positioning and mitigating surgical complications [28][29][30][31][32]. In a recent investigation by Tonutti et al, ML was employed to facilitate the diagnosis of intraoperative tumors [32].…”